| Apr 22, 2014
| 8:31 AM
Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
| Apr 24, 2014
| 8:41 AM
Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.
The proposed acquisition follows a flurry of billion-dollar deals by...
| May 22, 2014
| 11:35 AM
For 85% of kids with a terrible cancer called acute lymphoblastic leukemia, chemotherapy is a cure-but not for Emily Whitehead. Diagnosed at 5, she suffered an infection from her first round of chemo and nearly lost her legs. Then the cancer came back;...
| May 8, 2014
| 2:26 AM
One of China’s most venerable dissident journalists was paraded on state television Thursday morning, apologizing for spilling state secrets that embarrassed the Chinese Communist Party.
The public shaming of Gao Yu, a 70-year-old grandmother who...
| Mar 2, 2014
| 6:00 AM
BEIJING — The headline news on state-run Chinese Channel 13 was juicy: A mining tycoon and 35 others had been charged with running a mafia-style enterprise in Sichuan province, gunning down enemies in the street, bribing people and operating an...
| Mar 27, 2014
| 11:17 AM
Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits.
The presence of these...
| Feb 5, 2014
| 12:21 PM
The landmark decision by CVS Caremark on Wednesday to halt tobacco sales at its 7,600 U.S. drugstores by Oct. 1 ratchets up pressure on its larger rival, Deerfield-based Walgreen Co., to follow suit.
CVS, the nation’s No. 2 drugstore chain, said...
| Dec 17, 2013
| 7:44 AM
Ending a practice that some say creates a conflict of interest, British pharmaceutical company GlaxoSmithKline said Tuesday it would end its practice of paying doctors to promote its drugs.
Glaxo, maker of drugs such as the antidepressant Paxil, also...
| Nov 25, 2013
| 4:52 PM
Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration.
Federal regulators said Monday that the...
| Feb 5, 2014
| 5:11 PM
CVS Caremark Corp.'s imminent exit from the cigarette and tobacco business — an unprecedented move for a major pharmacy company — is being cheered by many medical professionals and lawmakers as a triumph of corporate responsibility over the...
| Jan 13, 2014
As human beings, we are at our best when we can be ourselves, when we live without fear of judgment or the pressures of putting on airs.
As workers, logically, it's no different. An employee living authentically, unencumbered by the distractions of...